The Medicines Company, Alnylam Announce Advance Development Candidate for Treatment of Hypercholesterolemia

The Medicines Company (NASDAQ: MDCO ) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) announced today that their strategic alliance has yielded a lead Development Candidate that is